Business, energy, technology, markets and global industry news from Business News Today

neurodegenerative disorders

PharmaDeviceNews neurodegenerative disorders
Representative image: AI-powered drug discovery research lab illustrating Insilico Medicine and SK Biopharmaceuticals’ $2.5 billion CNS neuroimmune drug development pact.
Pharma & Biotech

Why Insilico’s $2.5bn SK Biopharmaceuticals deal could reshape AI drug discovery

Find out how Insilico and SK Biopharmaceuticals are using AI to target neuroimmune CNS disorders in a $2.5B drug discovery pact.

Read More
Pharma & Biotech

Acurex Biosciences moves 15-lipoxygenase program closer to Parkinson’s disease clinical testing

Parkinson’s drugs still treat symptoms. Acurex’s ASAP grant puts 15-lipoxygenase and ferroptosis into sharper disease-modifying focus.

Read More